ART_ID field

Containing table:
Explanation of variable:
represents the antiretroviral treatment
Format of data:
character. see coding table for valid codings.

Coding Table

A set of extended ATC codes are being presented here in order to code both more specific on subtypes of the drugs, e.g. saquinavir hard and soft gel, but also to enable coding of drugs that are at their trial stage and have not yet been assigned an ATC code. To do this the drug will be assigned the code elements as far down the levels as possible. Given two examples to illustrate this:

Saquinavir - Hard Gel
Saquinavir - Soft Gel
Saquinavir - not specified

This will ensure the fidelity needed to distinguish between hard and soft gel and not specified, but also for analysis easily include all records which coding starts with J05AE01, regardless if the drug is hard or soft gel.

See the ​ATC Index for the individual codes. The extended ATC codes are listed below along with a subset of ATC codes relevant to ART.

Code (Extended ATC Codes)Anti-Retroviral Drugs
J05AART unspecified
J05AEPI unspecified
J05AE01Saquinavir (gel, not specified)
J05AE01-SQHSaquinavir hard gel (INVIRASE)
J05AE01-SQSSaquinavir soft gel (FORTOVASE)
J05AE02Indinavir (CRIXIVAN)
J05AE03Ritonavir (NORVIR)
J05AE03-HRitonavir high dose (NORVIR)
J05AE03-LRitonavir low dose (NORVIR)
J05AE04Nelfinavir (VIRACEPT)
J05AE05Amprenavir (AGENERASE)
J05AE07Fos-amprenavir (Telzir, Lexiva)
J05AE08Atazanavir (Reyataz)
J05AE09Tipranavir (Aptivus)
J05AE10Darunavir (TMC-114, Prezista)
J05AE-MOZMozenavir (DMP-450)
J05AFNRTI unspecified
J05AF01Zidovudine (AZT, RETROVIR)
J05AF02Didanosine (ddI) (VIDEX)
J05AF03Zalcitabine (ddC) (HIVID)
J05AF04Stavudine (d4T) (ZERIT)
J05AF05Lamivudine (3TC, EPIVIR)
J05AF06Abacavir (1592U89) (ZIAGEN)
J05AF07Tenofovir (VIREAD)
J05AF-AMDAmdoxovir (DADP)
J05AF-FOZFozivudine tidoxi
J05AF-LDNLodenosine (trialdrug)
J05AGNNRTI unspecified
J05AG01Nevirapine (VIRAMUN)
J05AG02Delavirdine (U-90152) (RESCRIPTOR)
J05AG03Efavirenz (DMP-266) (STOCRIN, SUSTIVA)
J05AG04Etravirine (TMC 125)
J05AG05Rilpivirine (TMC-278)
J05AG-DPC083DPC 083
J05AG-DPC961DPC 961
J05AG-EMVEmivirine (MKC442)
J05A-PBTParticipant in Blinded Trial
J05AR01Combivir (Zidovudine/Lamivudine)
J05AR02Kivexa (Lamivudine/Abacavir)
J05AR03Truvada (Tenofovir/Emtricabine)
J05AR04Trizivir (Zidovudine/Lamivudine/Abacavir)
J05AR05Douvir-N (Zidovudine/Lamivudine/Nevirapine)
J05AR06Atripla (Emtricitabine/Tenofovir/Efavirenz)
J05AR07Triomune (Stavudine/Lamivudine/Nevirapine)
J05AR08Eviplera/Complera (Emtricitabine/Tenofovir/Rilpivirine)
J05AR09Stribild (Emtricitabine/Tenofovir/Elvitegravir/Cobicistat)
J05AR10Kaletra/Aluvia (Lopinavir/Ritonavir)
J05AR10Lopinavir/Ritonavir (Kaletra). Former code: J05AE06
J05AR11Lamivudine, tenofovir disoproxil and efavirenz
J05AR12Lamivudine and tenofovir disoproxil
J05AR13Triumeq (Lamivudine, abacavir and dolutegravir)
J05AR14Darunavir and cobicistat
J05AR15Atazanavir and cobicistat
J05AR16Lamivudine and raltegravir
J05AR17Emtricitabine and tenofovir alafenamide
J05AR18Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
J05AR19Emtricitabine, tenofovir alafenamide and rilpivirine
J05AX07Enfuvirtide (Fuzeon, T-20)
J05AX08Raltegravir (Merck)
J05AX09Maraviroc (Pfizer)
J05AX-CABCabotegravir (GSK-744)
J05AX-VICVicriviroc (Schering)
L01XX05Hydroxyurea/Hydroxycarbamid (Litalir)